Back to Search
Start Over
Effect of Low Molecular Weight Heparan Sulphate on Angiogenesis in the Rat Cornea After Chemical Cauterization
- Source :
- Scopus-Elsevier
- Publication Year :
- 1994
- Publisher :
- Mary Ann Liebert Inc, 1994.
-
Abstract
- Vascularization of the cornea occurs in many pathological conditions and can result in loss of visual acuity. It is also thought that vascularization predisposes the cornea to reject grafts by facilitating the detection of foreign antigens in donor material. A rat corneal assay for angiogenesis was adopted in the present study to evaluate the possible angiostatic activity of a low molecular weight heparan sulphate (LMW-HS). Corneal lesions were induced by chemical cauterization at 2 mm from the corneoscleral limbus. Rats were randomized to receive two drops/eye four times daily, for 6 days, of a solution of LMW-HS in vehicle (2.5% carboxymethylcellulose), heparin, heparin plus hydrocortisone, or vehicle alone. After a 6 day-treatment period, the eyes were perfused with india ink and the degree of neovascularization was evaluated. In rats treated with vehicle alone a dense vascular network extending from the corneoscleral limbus to the cauterized site was observed; on the contrary, a markedly reduced vascular network was evidenced in animals treated with LMW-HS. The distribution of basic fibroblast growth factor (bFGF) in the cauterized cornea was also evaluated by using an immunohistochemical method. A marked bFGF immunoreactivity was demonstrated in corneal epithelium and stroma of control rats 12-48 hours after the cautery. These results lead to the assumption that LMW-HS could be used in ophthalmology to inhibit corneal neovascularization.
- Subjects :
- medicine.medical_specialty
Visual acuity
Hydrocortisone
genetic structures
Potassium Compounds
Angiogenesis
medicine.medical_treatment
Biology
animal tissue
Cornea
Immunoenzyme Techniques
Neovascularization
angiogenesis
Random Allocation
Ophthalmology
Corneoscleral Limbus
medicine
Animals
Corneal Neovascularization
Pharmacology (medical)
basic fibroblast growth factor, heparan sulfate
Rats, Wistar
Pharmacology
Nitrates
Heparan sulphate
Heparin
basic fibroblast growth factor
eye diseases
Rats
Surgery
Molecular Weight
medicine.anatomical_structure
Cauterization
Silver Nitrate
Drug Therapy, Combination
Female
Fibroblast Growth Factor 2
heparan sulfate
Heparitin Sulfate
sense organs
Ophthalmic Solutions
medicine.symptom
medicine.drug
Subjects
Details
- ISSN :
- 15577732 and 10807683
- Volume :
- 10
- Database :
- OpenAIRE
- Journal :
- Journal of Ocular Pharmacology and Therapeutics
- Accession number :
- edsair.doi.dedup.....092e6a6934f001f234dbf5203e926900
- Full Text :
- https://doi.org/10.1089/jop.1994.10.273